抗 PEG 产品参考文献

​​通过阅读文献发现关于我们聚乙二醇 (PEG) 产品的更多信息

下文列出了已发表论文的部分清单以及客户使用我们的抗 PEG RabMAb® 产品后给出的评价。

​​



抗-聚乙二醇抗体 [PEG-B-47] (ab51257)​

Toxicol Pathol ​41:970-83 (2013).
Rudmann DG  et al.
High Molecular Weight Polyethylene Glycol Cellular Distribution and PEG-associated Cytoplasmic Vacuolation Is Molecular Weight Dependent and Does Not Require Conjugation to Proteins. 



​Mol Cancer Ther​ 12:1816-28 (2013). 
Hendriks BS  et al. ​
ERBB2 expression level on HER2-targeted liposomal doxorubicin-mediated drug delivery: multiple low-affinity interactions lead to a threshold effect. 


​​
ACS Nano 6:8007-14 (2012).
Bitner BR  et al. 
Antioxidant carbon particles improve cerebrovascular dysfunction following traumatic brain injury. 



Bioconjug Chem 23:485-99 (2012). ​​​
Sherman MR  et al. 
Role of the methoxy group in immune responses to mPEG-protein conjugates. 


​​
Bioconjug Chem 23:248-63 (2012). ​
Cong Y  et al.
Site-specific PEGylation at histidine tags. 



​Shock 31:192-200 (2009). ​​​
Sakai H  et al. 
Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days. 



Mol Immunol. 2014 Feb;57(2):236-46
Saifer MG et al.
Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins. 


​​
J Control Release. 2013 Feb 10;165(3):183-90
Shiraishi K et al.
Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.



Bioconjug Chem. 2012 May 16;23(5):881-99.
Cheng TL et al.
Analytical measurement of PEGylated molecules.​


​​
​Int J Nanomedicine. 2012;7:2557-71.
Oberoi HS et al.
Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice.​



Soft Matter. 2014 Feb 14;10(6):831-9.
Schulz M et al.​
Lateral surface engineering of hybrid lipid-BCP vesicles and selective nanoparticle embedding.​​


​​
J Control Release. 2013 Nov 10;171(3):339-48. 
Desale SS et al. 
Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.​



​BioDrugs. 2014 Aug;28(4):393-402.​
Pink A et al.
Purification, Characterization and Plasma Half-Life of PEGylated Soluble Recombinant Non-HA-Binding CD44.​



J Immunol. 2013 Nov 1;191(9):4599-610. 
Suchard SJ et al. 
A monovalent anti-human CD28 domain antibody antagonist: preclinical efficacy and safety.


​​
Anal Bioanal Chem. 2012 Jan;402(3):1229-39.
Wang SJ et al. 
Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.



Bioconjug Chem. 2010 Jul 21;21(7):1264-70. 
Su YC et al.
Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies.



Integr Biol (Camb). 2014 Jul 21;6(8):766-80. 
Myers DE et al. 
CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells.


​​
Mol Pharm. 2012 May 7;9(5):1291-301.
Elliott VL et al. 
Evidence for metabolic cleavage of a PEGylated protein in vivo using multiple analytical methodologies.




​​更多产品参考文献,请访问 ​ab51257 产品参考文献页

抗-聚乙二醇抗体 [PEG-2-128] (ab133471

Mol Immunol 57:236-46 (2014).
Saifer MG  et al. ​
 
Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins.


​​
Bioconjug Chem. 2012 May 16;23(5):881-99.
Cheng TL et al.
Analytical measurement of PEGylated molecules.​




更多产品参考文献,请访问 ab133471 产品参考文献页

聚合二醇 (PEG) RabMab ELISA 试剂盒(ab138914)

J Interferon Cytokine Res 33:769-77 (2013). 
Lee JI  et al. 
Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b. 



Anal Chem 85:9630-7 (2013). ​​​
Liu Q  et al. 
Method for characterization of PEGylated bioproducts in biological matrixes. 


​​​
Korean J Gastroenterol 58:107-10 (2011).
Tae HJ  et al.
[A case of pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C]. 



Invest Ophthalmol Vis Sci 52:1392-403 (2011). ​
Peng S  et al. 
Claudin-19 and the barrier properties of the human retinal pigment epithelium. 



Invest Ophthalmol Vis Sci 51:3216-25 (2010). 
Peng S  et al. 
Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions.



For more product references, please visit ab138914 product reference page.


客户好评

“( PEG RabMAb 一抗,ab53449)的亲和力相对较高(低 nM)意味着我们可以广泛清洗检测孔(不含 Tween PBS),且不会去除特异性结合的抗体 - 从本质上来讲,这意味着我们的实验结果‘背景低’且‘信噪比高’。”

Abreview 提供 -


注册